Skip to main content
. 2024 Jun 30;36(3):282–297. doi: 10.21147/j.issn.1000-9604.2024.03.05

Figure 1.

Figure 1

Flowcharts of study design. (A) Flowchart of DNA and RNA next generation sequencing and clinicopathological and molecular features analysis in 355 NSCLC patients; (B) Treatment and prognostic analysis of enrolled NSCLC patients. NSCLC, non-small cell lung cancer; CT, computed tomography; GSS, genomic scar score; HRD, homologous recombination defect.